Mechanisms of Immune-Related Complications in Cancer Patients Treated with Immune Checkpoint Inhibitors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Mechanisms of Immune-Related Complications in Cancer Patients Treated with Immune Checkpoint Inhibitors ; volume:106 ; number:3-4 ; year:2021 ; pages:123-136 ; extent:14
Pharmacology ; 106, Heft 3-4 (2021), 123-136 (gesamt 14)
- Urheber
-
König, David
Läubli, Heinz
- DOI
-
10.1159/000509081
- URN
-
urn:nbn:de:101:1-2021040100140688316744
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- König, David
- Läubli, Heinz
Ähnliche Objekte (12)
Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Endocrine immune-related adverse events in patients with metastatic renal and urothelial cancer treated with immune checkpoint-inhibitors
SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019)
Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors
Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors
Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series
Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis
Immune-related aseptic meningitis and strategies to manage immune checkpoint inhibitor therapy: a systematic review
Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Endocrine immune-related adverse events in patients with metastatic renal and urothelial cancer treated with immune checkpoint-inhibitors
SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019)
Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors
Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors
Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series
Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis
Immune-related aseptic meningitis and strategies to manage immune checkpoint inhibitor therapy: a systematic review
Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Endocrine immune-related adverse events in patients with metastatic renal and urothelial cancer treated with immune checkpoint-inhibitors
SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019)
Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors
Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors
Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series
Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis